G

GordonMD Global Investments LP

7 employees

GordonMD Global Investments focused on investments in private and publicly traded global growth and innovative biopharma companies.

Investor insights

Sectors invested in

Biotechnology5

Life Science4

Therapeutics3

Genetics2

Biopharma2

Molecular Biology1

Gene Therapy1

Central Nervous System1

Health Care1

immuno-oncology and gene editing1

Inherited disease1

Gene therapy1

Genome engineering1

Cell therapy1

Genetic disease1

Cell engineering1

Funding rounds participated in

$115M sweet spot round size

Most of their 5 investments are in rounds between $36M and $123M

Investor type

Venture Capital

Basic info

Industry

financial services

Sectors

Financial Services

Finance

Biopharma

Venture Capital

Date founded

2021

Investments made

T

Taysha Gene Therapies raised $150M on August 14, 2023

Investors: RTW Investments, LP, Octagon Capital Advisors, PBM Capital Group, RA Capital Management, L.P., TCG X, The Invus Group, B Capital Group and GordonMD Global Investments LP

F

Flare Therapeutics raised $123M on March 22, 2023

Investors: ShangBay Capital, Eventide Asset Management, Nextech Invest, The Invus Group, Third Rock Ventures and GordonMD Global Investments LP

S

Spotlight Therapeutics raised $37M on March 22, 2022

Investors: EPIQ, Magnetic Ventures, Emerson Collective, GV and GordonMD Global Investments LP

S

SalioGen Therapeutics raised $115M on January 5, 2022

Investors: T. Rowe Price, EPIQ, RD Fund, D1 Capital Partners L.P. and GordonMD Global Investments LP

A

Antios Therapeutics raised $75M on November 3, 2021

Investors: GRA Venture Fund LLC, Sixty Degree Capital, RA Capital Management, L.P., LifeSci Venture Partners, Lumira Ventures, Pontifax Venture Capital, Soleus Capital Management, L.P. and GordonMD Global Investments LP